MAOB and Parkinson disease: Furthermore, Peretz and coworkers [43] reported that the time from a MAO-B inhibitor prescription until the initiation of dopamine agonists or levodopa therapy was longer in Parkinson’s patients treated with selegiline in comparison with rasagiline treatment.